Become A Member

Faculty interested in becoming a member should contact the Research Program Leader(s) of a specific group (mentioned below) and send them his or her completed application and supporting documentation. Upon review, the Program Leader will forward the application package to the Membership Committee for final review and approval.

Research Programs

Research Programs supported by the CCSG are critical to the success of the NYUCI. Research Programs meet full NCI guidelines, including benchmarks for competitively funded research and highly interactive, multi-investigator projects. All Cancer Institute members belong to one of the eight of the Scientific Research Programs and are eligible to join up to two. Below are the Research Programs open for membership.

Disease-Based Research Programs

Melanoma	Iman Osman [1]	Nina Bhardwaj [2]
Breast Cancer	Robert Schneider [3]	Silvia Formenti [4]
Genitourinary	Michael Garabedian [5]	Samir Taneja [6]

Basic Science-Based Research Programs

Cancer Immunology	Sandra Demaria [7]	Michael Dustin [8]
Growth Control	Wei Dai [9]	Michele Pagano [10]
Stem Cell Biology	Iannis Aifantis [11]	Ruth Lehmann [12]

Population-Based Research Programs

Environmental and Molecular Carcinogenesis	Max Costa [13]	William Rom [14]
Epidemiology & Cancer Control	Richard Hayes [15]	Brian Schmidt [16]

Disease Management Groups

In addition to the Research Programs, members are also encouraged to attend meetings of the Disease Management Groups (DMGs) that focus on clinical issues related to the full spectrum of human cancers. The DMGs are critical to the research mission of the NYUCI. Their purpose is to ensure multidisciplinary care, prioritize disease specific clinical research protocols and most importantly serve as incubators for investigator-initiated clinical and translational research studies. All DMGs are linked to one or more of the CCSG Research Programs.

The multidisciplinary DMG teams meet regularly to plan, prioritize, and successfully implement disease or organ-specific protocols, as well as develop systems for banking human samples. DMGs may meet as more classic multidisciplinary "Tumor Boards," with an additional focus on translational research. Active involvement of more basic scientists is encouraged since these investigators can appreciate the challenges of diagnosis and effective therapy. Involvement in a DMG is not required for NYU Cancer Institute membership, however, it is encouraged.

Breast Cancer	Silvia Formenti [4]	Yelena Novik [17]
Endocrine Cancer	Keith Heller [18]	Kepal Patel [19]
Gastrointestinal Cancer	Lawrence Leichman [20]	Elliot Newman [21]
Genitourinary Cancer (Prostate, Bladder, & Kidney)	Samir Taneja [6]	Anna Ferrari [22]
Gynocologic Cancers	John Curtin [23]	Amy Tiersten [24]
Head and Neck Cancer	Mark DeLacure [25]	Nicholas Sanfilippo [26]
Hematological Malignancies	Lawrence Gardner [27]
Melanoma	Iman Osman [1]	Anna Pavlick [28]
Neuro-Oncology (Brain & Spinal Cord Cancers)	Jeffery Allen [29]	Ashwatha Narayana [30]
Pediatric Cancers	Elizabeth Raetz [31]	Sharon Gardner [32]
Phase I Clinical Trials	Anna Pavlick [28]	Franco Muggia [33]
Sarcoma Oncology	Linda Granowetter [34]	Timothy Rapp [35]
Thoracic Oncology	Harvey Pass [36]	Abraham Chachoua [37]